The researchers, who reported their findings in a recent issue of BMC Complementary and Alternative Medicine, suggest that the findings could pave the way for clinical testing of the compounds
on human colon cancer, which is the second most common cancer in women and the third in men.
Not exact matches
Further research uncovered a broad spectrum of cell surface stem cell markers (e.g., CD133, CD44, and CD24) that allow the identification of CSCs in
human solid tumors, including brain, breast, prostate, pancreas, liver, ovary, skin,
colon cancers, and melanoma (3 - 6)(Figure 1 based
on 7).
These compounds seem to have a positive effect
on general health, intestinal function and flora and the prevention of
colon cancer in
humans.
However, in
human trials, brewer's rice has been shown to have very positive effects
on colon cancer, kidney and liver disease [17, 18, 19, 20, 21].